Skip to main content
Clinical Trials/NCT07371091
NCT07371091Not yet recruitingNot Applicable

Monitoring the Use of Collagen Dura Membrane - Repair (DMR) in the Post-market Phase

Collagen Matrix2 sites in 1 country110 target enrollmentStarted: July 1, 2026Last updated:

Trial Snapshot

Phase
Not Applicable
Status
Not yet recruiting
Sponsor
Enrollment
110
Locations
2
Primary Endpoint
Rate of Revision Surgery

Study Overview

Brief Summary

Monitoring the Use of Collagen Dura Regeneration Membrane - Repair (DMR) in the Post-market Phase.

Detailed Description

A multi-center (up to 4 sites) clinical case series of 110 patients treated with Collagen Dura Regeneration Membrane - Repair (DMR) for a dural defect in the dura mater will be evaluated prospectively. The primary endpoint is the rate of adverse events related to the Subject Device requiring surgical intervention. Patients will have a follow-up evaluation post-operatively in line with standard or care of the study site, and 8 months after the initial surgery. No original patient records or personal identifying information will be disclosed to CMI.

Study Design

Study Type
Observational
Observational Model
Cohort
Time Perspective
Prospective

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Patients with a dural defect requiring repair with a dural substitute as per routine clinical practice
  • Patient is 18 years or older
  • Patient of child-bearing potential is not pregnant or nursing
  • Participant is willing and able to provide consent

Exclusion Criteria

  • Patients with a known history of hypersensitivity to bovine derived materials
  • Patients that are non-English speaking
  • Patients requiring legal representation

Outcomes

Primary Outcomes

Rate of Revision Surgery

Time Frame: at least one timepoint at 8 months or more post-surgery

Rate of adverse events related to the Subject Device requiring surgical intervention.

Secondary Outcomes

  • Rate of Adverse Events(at least one timepoint at 8 months or more post-surgery)
  • Product Performance(at least one timepoint at 8 months or more post-surgery)
  • Product Handling at Implantation(Initial surgery)
  • Product Adaptability at Implantation(Initial surgery)

Investigators

Sponsor
Collagen Matrix
Sponsor Class
Industry
Responsible Party
Sponsor

Study Sites (2)

Loading locations...

Similar Trials